LexDanaLexDanabeta
Inventor

MARK C. BENYUNES

Inventor
US

Overview

3→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
12,128,103Adjuvant treatment of HER2-positive breast cancer202411,992,529Adjuvant treatment of HER2-positive breast cancer202411,638,756Adjuvant treatment of HER2-positive breast cancer2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to GENENTECH INC (3)· patent assignee history
2023–2024Patents assigned to HOFFMANN LA ROCHE (3)· patent assignee history
2023–2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENENTECH INC32023–2024
HOFFMANN LA ROCHE32023–2024
Locations
LocationPatentsSpan
US32023–2024